Skip to main content

Mercier Johanna's Form 4 filing

Gilead Sciences, Inc. (GILD) · filed Aug 18, 2026

Accession no.
0001782135-26-000028
Filed
Aug 18, 2026, 6:54 PM ET
Trade date
Aug 17, 2026
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.85M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mercier JohannaCIK 0001782135Officer (Chief Comm & Corp Aff Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 17, 2026Common StockMOption exerciseAcquired+23,110$66.64+$1,540,050.4144,344Direct
Aug 17, 2026Common StockMOption exerciseAcquired+1,890$72.34+$136,722.6146,234Direct
Aug 17, 2026Common StockSSaleDisposed−16,530$137.37F2−$2,270,643.45129,704Direct
Aug 17, 2026Common StockSSaleDisposed−11,470$138.04F3−$1,583,264.89118,234Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 17, 2026Common StockMOption exerciseDisposed−23,110$0.00$00Direct
Aug 17, 2026Common StockMOption exerciseDisposed−1,890$0.00$069,960Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Sale prices for the transactions reported range from $136.74 to $137.73. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Referenced by the price of 1 transaction in Table I.

F3

Sale prices for the transactions reported range from $137.75 to $138.36. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)